A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage

Cancer Research

Volumn 68, Issue 4, 2008, Pages 1162-1169

  Daouti, Sherif ^a   Li, Wen Hui ^a   Qian, Hong ^a   Huang, Kuo Sen ^a   Holmgren, Janna ^a   Levin, Wayne ^a   Reik, Linda ^a   McGady, Debra Lucas ^a   Gillespie, Paul ^a   Perrotta, Agostino ^a   Bian, Hongjin ^a   Reidhaar Olson, John F ^a   Bliss, Sarah A ^a   Olivier, Andree R ^a   Sergi, Joseph A ^a   Fry, David ^a   Danho, Waleed ^a   Ritland, Steve ^a   Fotouhi, Nader ^a   Heimbrook, David ^a   Niu, Huifeng ^a   more..

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CELECOXIB; CISPLATIN; CRK ASSOCIATED SUBSTRATE PROTEIN; ENZYME INHIBITOR; ETOPOSIDE; PROTEIN P53; SERINE; SMALL INTERFERING RNA; THIENOPYRIDONE; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR CELL; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; ANOIKIS; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CRK-ASSOCIATED SUBSTRATE PROTEIN; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HELA CELLS; HT29 CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN TYROSINE PHOSPHATASES; PYRIDINES; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 39449127662     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2349     Document Type: Article

References (22)

1. Stephens BJ, Han H, Gokhale V, Von Hoff DD. PRL phosphatases as potential molecular targets in cancer. Mol Cancer Ther 2005;4:1653-61.
2. Cates CA, Michael RL, Stayrook KR, et al. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 1996;110:49-55.
3. Wang Q, Holmes DI, Powell SM, Lu QL, Waxman J. Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Lett 2002;175:63-9.
4. Saha S, Bardelli A, Buckhaults P, et al. A phosphatase associated with metastasis of colorectal cancer. Science 2001;294:1343-6.
5. Bardelli A, Saha S, Sager JA, et al. PRL-3 expression in metastatic cancers. Clin Cancer Res 2003;9:5607-15.
6. Wu X, Zeng H, Zhang X, et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 2004;164:2039-54.
7. Miskad UA, Semba S, Kato H, et al. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch 2007;450:303-10.
8. Polato F, Codegoni A, Fruscio R, et al. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 2005;11:6835-9.
9. Radke I, Gotte M, Kersting C, Mattsson B, Kiesel L, Wulfing P. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 2006;95:347-54.
10. Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate Rho family GTPases to promote invasion and motility. Cancer Res 2006;66:3153-61.
11. Guertin KR, Setti L, Qi L, et al. Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity. Bioorg Med Chem Lett 2003;13:2895-8.
12. Neri A, Welch D, Kawaguchi T, Nicolson GL. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 1982;68:507-17.
13. Rouleau C, Roy A, St. Martin T, et al. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol Cancer Ther 2006;5:219-29.
14. Kato H, Semba S, Miskad UA, Seo Y, Kasuga M, Yokozaki H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 2004;10:7318-28.
15. Kook S, Shim SR, Choi SJ, et al. Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells. Mol Biol Cell 2000;11:929-39.
16. Casanova I, Parreno M, Farre L, et al. Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas. Int J Cancer 2006;118:2381-9.
17. Kim W, Kook S, Kim DJ, Teodorof C, Song WK. The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. J Biol Chem 2004;279:8333-42.
18. Cabodi S, Tinnirello A, Di Stefano P, et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006;66:4672-80.
19. Defilippi P, Di Stefano P, Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 2006;16:257-63.
20. Wei L, Yang Y, Zhang X, Yu Q. Cleavage of p130Cas in anoikis. J Cell Biochem 2004;91:325-35.
21. Achiwa H, Lazo JS. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Res 2007;67:643-50.
22. Kozlov G, Cheng J, Ziomek E, Banville D, Gehring K, Ekiel I. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. J Biol Chem 2004;279:11882-9.